CIBC Asset Management
BIOR

CIBC Asset Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

CIBC Asset Management’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,511
Closed -$16.6K – 1229
2024
Q1 		$16.6K Hold
1,511
– – ﹤0.01% 1125
2023
Q4 		$20.4K Hold
1,511
– – ﹤0.01% 1091
2023
Q3 		$32.8K Hold
1,511
– – ﹤0.01% 1031
2023
Q2 		$58.2K Hold
1,511
– – ﹤0.01% 1058
2023
Q1 		$41.9K Buy
+1,511
New +$51.2K ﹤0.01% 1039

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

CIBC Asset Management's BIOR Position: Q2 2024 in Review

CIBC Asset Management sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q2 2024, closing a stake of 1,511 shares — an estimated $16.6K sold.

CIBC Asset Management first reported a position in BIOR in Q1 2023 and held it in 5 quarters. The position peaked at $58.2K in Q2 2023. 26 funds tracked by Wall St. Rank hold BIOR as of Q2 2024.

  • CIBC Asset Management reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • CIBC Asset Management sold 1,511 Biora Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $16.6K.
  • CIBC Asset Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q1 2023 and held it in 5 quarters.
  • CIBC Asset Management's Biora Therapeutics, Inc. Common Stock position peaked at $58.2K in Q2 2023.
  • 26 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q2 2024.

Based on CIBC Asset Management's 13F filing for Q2 2024, filed 1 Aug 2024.